Terms: = Liver cancer AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR AND Prognosis
17 results:
1. Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21.
Sui Y; Liu Q; Xu C; Ganesan K; Ye Z; Li Y; Wu J; Du B; Gao F; Song C; Chen J
Cell Death Dis; 2024 Jan; 15(1):67. PubMed ID: 38238320
[TBL] [Abstract] [Full Text] [Related]
2. miR-552 promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma by targeting foxo1.
Cheng Z; Cheng N; Tang X; Yang F; Ma W; Yu Q; Tang H; Xiao Q; Lei Z
Exp Cell Res; 2023 Oct; 431(1):113741. PubMed ID: 37549804
[TBL] [Abstract] [Full Text] [Related]
3. LITAF inhibits colorectal cancer stemness and metastatic behavior by regulating foxo1-mediated SIRT1 expression.
Guan J; Zhang ZY; Sun JH; Wang XP; Zhou ZQ; Qin L
Clin Exp Metastasis; 2023 Aug; 40(4):309-320. PubMed ID: 37266842
[TBL] [Abstract] [Full Text] [Related]
4. A miR-9-5p/foxo1/CPEB3 Feed-Forward Loop Drives the Progression of Hepatocellular Carcinoma.
Hu H; Huang W; Zhang H; Li J; Zhang Q; Miao YR; Hu FF; Gan L; Su Z; Yang X; Guo AY
Cells; 2022 Jul; 11(13):. PubMed ID: 35805200
[TBL] [Abstract] [Full Text] [Related]
5. CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma.
Li J; Hu ZQ; Yu SY; Mao L; Zhou ZJ; Wang PC; Gong Y; Su S; Zhou J; Fan J; Zhou SL; Huang XW
Cancer Res; 2022 Mar; 82(6):1055-1069. PubMed ID: 35045986
[TBL] [Abstract] [Full Text] [Related]
6. CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARα/CCL2 pathway.
Wang X; Sheng W; Xu T; Xu J; Gao R; Zhang Z
Aging (Albany NY); 2021 Apr; 13(8):11969-11987. PubMed ID: 33891564
[TBL] [Abstract] [Full Text] [Related]
7. SUMO-Activating Enzyme Subunit 1 (SAE1) Is a Promising Diagnostic cancer Metabolism Biomarker of Hepatocellular Carcinoma.
Ong JR; Bamodu OA; Khang NV; Lin YK; Yeh CT; Lee WH; Cherng YG
Cells; 2021 Jan; 10(1):. PubMed ID: 33477333
[TBL] [Abstract] [Full Text] [Related]
8. Uncovering the potential differentially expressed miRNAs as diagnostic biomarkers for hepatocellular carcinoma based on machine learning in The cancer Genome Atlas database.
Zhao X; Dou J; Cao J; Wang Y; Gao Q; Zeng Q; Liu W; Liu B; Cui Z; Teng L; Zhang J; Zhao C
Oncol Rep; 2020 Jun; 43(6):1771-1784. PubMed ID: 32236623
[TBL] [Abstract] [Full Text] [Related]
9. Transmembrane protein 106C promotes the development of hepatocellular carcinoma.
Luo X; Han G; Lu R; Guan S; Wang Y; Ju L; Chen L; Shao J; Bian Z
J Cell Biochem; 2020 Nov; 121(11):4484-4495. PubMed ID: 32037603
[TBL] [Abstract] [Full Text] [Related]
10. HBX-induced miR-5188 impairs foxo1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z
Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788
[TBL] [Abstract] [Full Text] [Related]
11. Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of foxo1 and Bim pathway.
Chi HC; Chen SL; Cheng YH; Lin TK; Tsai CY; Tsai MM; Lin YH; Huang YH; Lin KH
Cell Death Dis; 2016 Aug; 7(8):e2324. PubMed ID: 27490929
[TBL] [Abstract] [Full Text] [Related]
12. MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation.
Jiang J; Zhang Y; Guo Y; Yu C; Chen M; Li Z; Tian S; Sun C
Oncotarget; 2015 Mar; 6(8):6359-72. PubMed ID: 25849943
[TBL] [Abstract] [Full Text] [Related]
13. Selective insulin resistance in hepatocyte senescence.
Aravinthan A; Challis B; Shannon N; Hoare M; Heaney J; Alexander GJM
Exp Cell Res; 2015 Feb; 331(1):38-45. PubMed ID: 25263463
[TBL] [Abstract] [Full Text] [Related]
14. From cirrhosis to hepatocellular carcinoma in HCV-infected patients: genes involved in tumor progression.
Wang Y; Li J; Chen J; Liu L; Peng Z; Ding J; Ding K
Eur Rev Med Pharmacol Sci; 2012 Aug; 16(8):995-1000. PubMed ID: 22913147
[TBL] [Abstract] [Full Text] [Related]
15. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
[TBL] [Abstract] [Full Text] [Related]
16. Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice.
Xu X; Kobayashi S; Qiao W; Li C; Xiao C; Radaeva S; Stiles B; Wang RH; Ohara N; Yoshino T; LeRoith D; Torbenson MS; Gores GJ; Wu H; Gao B; Deng CX
J Clin Invest; 2006 Jul; 116(7):1843-52. PubMed ID: 16767220
[TBL] [Abstract] [Full Text] [Related]
17. Biological prognostic factors in adult soft tissue sarcomas.
Ottaiano A; De Chiara A; Fazioli F; Talamanca AA; Mori S; Botti G; Milano A; Apice G
Anticancer Res; 2005; 25(6C):4519-26. PubMed ID: 16334136
[TBL] [Abstract] [Full Text] [Related]
